WDR3

WDR3 is a nuclear WD-repeat protein with dual roles in ribosome biogenesis and oncogenic signaling (PMID:20392698, PMID:10395803). As a component of the small-subunit pre-rRNA processing machinery, WDR3 is required for 18S rRNA processing and 40S ribosomal subunit synthesis; its depletion impairs precursor rRNA maturation and dampens RNA polymerase I activity, and in p53-competent cells triggers a ribosomal stress response in which RPL11 sequesters MDM2 to activate p53 and impose G1 arrest (PMID:20392698). This biogenesis function is developmentally essential, as homozygous Wdr3 knockout is embryonic lethal in mice (PMID:36463953). In cancer contexts WDR3 operates as a ubiquitin-ligase-associated adaptor and signaling driver: it serves as a substrate receptor for the CRL4 (Cul4-DDB1) E3 complex that binds and ubiquitylates the WNK-regulated kinases OSR1 and SPAK, linking it to ion homeostasis (PMID:31614064), and it directs ubiquitination of multiple transcription factors and readers to reshape gene expression — promoting K63-linked ubiquitination of YTHDC1 to drive its cytoplasmic relocalization and stabilize TGF-α mRNA (PMID:41395298), degrading USF2 to repress RASSF1A transcription (PMID:36905106), and engaging GATA4 to upregulate YAP1 and activate Hippo pathway signaling (PMID:33648545). WDR3 also undergoes liquid-liquid phase separation through its intrinsically disordered region, forming condensates that support tumor progression (PMID:40646517).

1. 1999 Medium

   Established the molecular identity of WDR3 — that it encodes a nuclear WD-repeat protein, defining a scaffold-type architecture and subcellular compartment for all later functional work.

   Evidence cDNA cloning, sequence/domain analysis, FISH chromosomal mapping, and expression profiling

   PMID:10395803

   Open questions at the time

   • Nuclear localization inferred from sequence rather than directly imaged
   • No functional assay linking the WD repeats to a specific partner or pathway
2. 2010 High

   Defined WDR3's core cellular function in 18S rRNA processing and 40S subunit synthesis, and showed its loss triggers a p53-dependent ribosomal stress checkpoint, explaining how WDR3 depletion arrests proliferation.

   Evidence siRNA knockdown with rRNA processing assays, PolI activity measurement, cell-cycle flow cytometry, and p53/MDM2/RPL11 epistasis in p53-competent vs p53-null cells

   PMID:20392698

   Open questions at the time

   • Precise position of WDR3 within the SSU processome not resolved
   • Direct rRNA or processing-factor binding partners not identified
3. 2019 Medium

   Revealed an unexpected second role beyond ribosome biogenesis — WDR3 acts as a CRL4 substrate receptor coupling WNK-dependent phosphorylation of OSR1/SPAK to their ubiquitylation, placing WDR3 in ion homeostasis signaling.

   Evidence Affinity pulldown with mass spectrometry, co-IP, and proteasomal/neddylation inhibitor assays under osmotic stress

   PMID:31614064

   Open questions at the time

   • Single lab without independent confirmation
   • Physiological consequence of OSR1/SPAK ubiquitylation on ion transport not measured
   • Whether substrate-receptor role generalizes to other targets unaddressed
4. 2021 Medium

   Connected WDR3 to oncogenic transcriptional programs, showing it drives GATA4 nuclear translocation to upregulate YAP1 and activate Hippo signaling in pancreatic cancer.

   Evidence Co-IP, nuclear fractionation/immunofluorescence, RT-qPCR, and knockdown with colony-formation and invasion assays

   PMID:33648545

   Open questions at the time

   • Interaction shown by co-IP only, no in vitro reconstitution
   • Mechanism by which WDR3 promotes GATA4 translocation unknown
   • Direct vs indirect effect on YAP1 transcription not separated
5. 2022 Medium

   Demonstrated that WDR3 is developmentally essential, with complete loss being embryonic lethal, while partial loss is tolerated without measurable rRNA deficit.

   Evidence Germline heterozygous/homozygous knockout mouse, X-gal staining, immunohistochemistry, RT-PCR, and behavioral assays

   PMID:36463953

   Open questions at the time

   • Developmental stage and cause of lethality not defined
   • Tissue-specific requirements not dissected
   • Mechanism linking essentiality to ribosome biogenesis vs other roles not established
6. 2023 Medium

   Extended WDR3's ubiquitin-directed regulation to transcription factor turnover, showing it degrades USF2 to suppress RASSF1A and promote prostate cancer stemness.

   Evidence Co-IP, ChIP, luciferase reporter, ubiquitination assay, and xenograft mouse model

   PMID:36905106

   Open questions at the time

   • E3 ligase mediating USF2 ubiquitination not identified
   • Single lab study
   • Whether degradation requires the CRL4 association seen for OSR1/SPAK unknown
7. 2025 Medium

   Showed WDR3 controls m6A-reader fate, facilitating K63-linked ubiquitination of YTHDC1 to shift it to the cytoplasm and stabilize TGF-α mRNA, driving pancreatic cancer metastasis.

   Evidence Co-IP, K63-linkage-specific ubiquitination assay, subcellular fractionation, mRNA stability assay, and rescue experiments

   PMID:41395298

   Open questions at the time

   • Ubiquitin ligase responsible not identified
   • Single lab
   • Link between K63 ubiquitination and cytoplasmic export mechanism unresolved
8. 2025 Medium

   Identified a biophysical mode of action — WDR3 forms liquid-liquid phase-separated condensates via its IDR that support osteosarcoma progression and are druggable by nilotinib.

   Evidence Droplet formation assay, FRAP, IDR mutagenesis, hnRNPA1-IDR domain-swap rescue, molecular docking, and xenograft model

   PMID:40646517

   Open questions at the time

   • Functional cargo or clients of the condensates not defined
   • Relationship of LLPS to ribosome biogenesis or ubiquitin functions unknown
   • Direct nilotinib-WDR3 binding shown only by docking

• How WDR3's conserved ribosome-biogenesis role mechanistically relates to its multiple cancer-associated ubiquitin and transcription-factor functions, and whether these reflect distinct protein pools or a unified scaffolding activity, remains unresolved.
• No structural model placing WDR3 in either the SSU processome or a defined ubiquitin complex
• Cancer-context functions each rest on single-lab studies
• Whether LLPS underlies the diverse interactions is untested